Pediatric Urologic Oncology Series: Surgeon Focused Update of the Changes to the New Children's Oncology Group Study of Unilateral Favorable Histology Wilms Tumor (AREN2231).
This publication provides a surgeon-focused update on changes associated with the new Children's Oncology Group AREN2231 study for unilateral favorable-histology Wilms tumor.
Open original publication →What the AI sees
This publication provides a surgeon-focused update on changes associated with the new Children's Oncology Group AREN2231 study for unilateral favorable-histology Wilms tumor.
Research significance
The record establishes only that clinically relevant study changes are discussed; it is reasonable but unproven to hypothesize that these changes could refine surgical management, treatment selection, or protocol implementation for children with unilateral favorable-histology Wilms tumor.
Source abstract
No abstract available.